Floatz logo

HUMAN IMMUNOGLOBULINS

Unverricht-Lundborg Disease

Azienda Socio Sanitaria Territoriale di Mantovaother_biologicalPhase 3Dormant
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Unverricht-Lundborg Disease cohort.

Asset / SponsorPhaseRating
Brivaracetam
UCB Pharma SA
Phase 3BB
Brv
UCB Pharma
Phase 3BB
Ropinirole
University of Turku
Phase 2CCC

Same molecule, other indications

HUMAN IMMUNOGLOBULINS is also rated in:

Alzheimer diseaseDormant
BB
Indicative ·
70 / 100
View asset →
Post-Polio SyndromeDormant
BB
Indicative ·
67 / 100
View asset →
epilepsyDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →